Nykredit A/S’s AbbVie ABBV Stock Holding History

Nykredit A/S’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$161M	Buy	+640,558	New	+$138M	0.51%	47

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Nykredit A/S's ABBV Position: Q2 2026 in Review

Nykredit A/S opened a new position in AbbVie (ABBV) in Q2 2026: 640,558 shares worth $161M. The stake represents 0.51% of the portfolio and ranks #47 among its holdings.

3,621 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Nykredit A/S held 640,558 shares of AbbVie worth $161M as of Q2 2026.
AbbVie was a new Nykredit A/S position in Q2 2026.
AbbVie made up 0.51% of Nykredit A/S's portfolio in Q2 2026, its #47 holding.
3,621 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Nykredit A/S's 13F filing for Q2 2026, filed 13 Aug 2026.